{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T11:50:14Z","timestamp":1791633014500,"version":"4.3.4"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thespinejournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Spine Journal"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.spinee.2026.09.007","type":"journal-article","created":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T22:55:18Z","timestamp":1789253718000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Costs and outcomes of recombinant human bone morphogenetic protein-2 usage in single-level posterior or transforaminal lumbar interbody fusion in a propensity score-matched national, retrospective cohort"],"prefix":"10.1016","author":[{"given":"Austin R.","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob W.","family":"McDevitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parth N.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cade F.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew Trice","family":"Pickens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2474-7857","authenticated-orcid":false,"given":"Theodore A.","family":"Joaquin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kranti C.","family":"Rumalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Plantz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler M.","family":"Compton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron K.","family":"Hoyt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew W.","family":"Colman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wellington K.","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alpesh A.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srikanth N.","family":"Divi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.spinee.2026.09.007_bib0001","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.2106\/JBJS.24.01205","article-title":"Efficacy and safety of osteobiologics for lumbar spinal fusion: a systematic review and network meta-analysis","volume":"107","author":"Ambrosio","year":"2025","journal-title":"J. Bone Joint Surg. Am."},{"issue":"12","key":"10.1016\/j.spinee.2026.09.007_bib0002","doi-asserted-by":"crossref","first-page":"E729","DOI":"10.1097\/BRS.0000000000003372","article-title":"Comparative clinical effectiveness and safety of bone morphogenetic protein versus autologous iliac crest bone graft in lumbar fusion: a meta-analysis and systematic review","volume":"45","author":"Liu","year":"2020","journal-title":"Spine"},{"issue":"12","key":"10.1016\/j.spinee.2026.09.007_bib0003","doi-asserted-by":"crossref","first-page":"877","DOI":"10.7326\/0003-4819-158-12-201306180-00005","article-title":"Safety and effectiveness of recombinant human bone morphogenetic protein-2 for spinal fusion: a meta-analysis of individual-participant data","volume":"158","author":"Simmonds","year":"2013","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.spinee.2026.09.007_bib0004","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.3390\/bioengineering10091005","article-title":"Current status of recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillofacial surgery: should it be continued?","volume":"10","author":"On","year":"2023","journal-title":"Bioengineering"},{"issue":"19","key":"10.1016\/j.spinee.2026.09.007_bib0005","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1039\/D4BM00848K","article-title":"Advances in implants and bone graft types for lumbar spinal fusion surgery","volume":"12","author":"Cheers","year":"2024","journal-title":"Biomater Sci"},{"issue":"19","key":"10.1016\/j.spinee.2026.09.007_bib0006","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1097\/BRS.0b013e3181ecf6e4","article-title":"Off-label use of bone morphogenetic proteins in the United States using administrative data","volume":"35","author":"Ong","year":"2010","journal-title":"Spine"},{"issue":"6","key":"10.1016\/j.spinee.2026.09.007_bib0007","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.spinee.2023.01.012","article-title":"Trends, payments, and costs associated with BMP use in Medicare beneficiaries undergoing spinal fusion","volume":"23","author":"Wadhwa","year":"2023","journal-title":"Spine J"},{"issue":"26","key":"10.1016\/j.spinee.2026.09.007_bib0008","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1097\/BRS.0b013e31820bc9e5","article-title":"Outcomes for single-level lumbar fusion: the role of bone morphogenetic protein","volume":"36","author":"Cahill","year":"2011","journal-title":"Spine"},{"issue":"1","key":"10.1016\/j.spinee.2026.09.007_bib0009","first-page":"14","article-title":"Guideline update for the performance of fusion procedures for degenerative disease of the lumbar spine. Part 3: assessment of economic outcome","volume":"21","author":"Ghogawala","year":"2014","journal-title":"J Neurosurg: Spine"},{"issue":"21","key":"10.1016\/j.spinee.2026.09.007_bib0010","doi-asserted-by":"crossref","first-page":"E1101","DOI":"10.1097\/BRS.0b013e3181de4f2e","article-title":"Bone union rate with autologous iliac bone versus local bone graft in posterior lumbar interbody fusion","volume":"35","author":"Ito","year":"2010","journal-title":"Spine"},{"issue":"3","key":"10.1016\/j.spinee.2026.09.007_bib0011","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.spinee.2017.08.230","article-title":"Comparison of transforaminal lumbar interbody fusion outcomes in patients receiving rhBMP-2 versus autograft","volume":"18","author":"Khan","year":"2018","journal-title":"Spine J"},{"issue":"10","key":"10.1016\/j.spinee.2026.09.007_bib0012","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1016\/j.jocn.2014.02.021","article-title":"Systematic review and meta-analysis of minimally invasive transforaminal lumbar interbody fusion rates performed without posterolateral fusion","volume":"21","author":"Bevevino","year":"2014","journal-title":"J Clin Neurosc"},{"issue":"2","key":"10.1016\/j.spinee.2026.09.007_bib0013","first-page":"236","article-title":"Comparison of transforaminal and posterior lumbar interbody fusion outcomes in patients receiving a novel allograft versus rhBMP-2: a radiographic and patient-reported outcomes analysis","volume":"41","author":"Hani","year":"2024","journal-title":"J Neurosurg: Spine"},{"issue":"4","key":"10.1016\/j.spinee.2026.09.007_bib0014","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1177\/21925682241310864","article-title":"Cost-effectiveness analyses of bone morphogenetic protein 2 (rhBMP-2) in spinal fusion: a systematic review","volume":"15","author":"Nunna","year":"2025","journal-title":"Global Spine J"},{"key":"10.1016\/j.spinee.2026.09.007_bib0015","unstructured":"PINC AI Healthcare Data White Paper: data that informs and performs. 2021."},{"issue":"6","key":"10.1016\/j.spinee.2026.09.007_bib0016","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/BRS.0000000000005372","article-title":"Current use and complications associated with bone morphogenetic protein in spine fusion surgery: a review of 9809 patients","volume":"51","author":"Korsun","year":"2026","journal-title":"Spine"},{"issue":"11","key":"10.1016\/j.spinee.2026.09.007_bib0017","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"issue":"2","key":"10.1016\/j.spinee.2026.09.007_bib0018","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/pst.433","article-title":"Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies","volume":"10","author":"Austin","year":"2011","journal-title":"Pharm Stat"},{"key":"10.1016\/j.spinee.2026.09.007_bib0019","unstructured":"Reserve SLF. Consumer price index for all urban consumers: medical care in U.S. city average. 2024."},{"issue":"1","key":"10.1016\/j.spinee.2026.09.007_bib0020","first-page":"106","article-title":"Guideline update for the performance of fusion procedures for degenerative disease of the lumbar spine. Part 16: bone graft extenders and substitutes as an adjunct for lumbar fusion","volume":"21","author":"Kaiser","year":"2014","journal-title":"J Neurosurg: Spine"},{"issue":"12","key":"10.1016\/j.spinee.2026.09.007_bib0021","doi-asserted-by":"crossref","first-page":"890","DOI":"10.7326\/0003-4819-158-12-201306180-00006","article-title":"Effectiveness and harms of recombinant human bone morphogenetic protein-2 in spine fusion: a systematic review and meta-analysis","volume":"158","author":"Fu","year":"2013","journal-title":"Ann Intern Med"},{"issue":"14","key":"10.1016\/j.spinee.2026.09.007_bib0022","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/BRS.0000000000000971","article-title":"A systematic review of lumbar fusion rates with and without the use of rhBMP-2","volume":"40","author":"Galimberti","year":"2015","journal-title":"Spine"},{"issue":"6","key":"10.1016\/j.spinee.2026.09.007_bib0023","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1007\/s00264-016-3149-8","article-title":"Bone morphogenetic protein use in spine surgery\u2014complications and outcomes: a systematic review","volume":"40","author":"Faundez","year":"2016","journal-title":"Int Orthop"},{"issue":"18","key":"10.1016\/j.spinee.2026.09.007_bib0024","doi-asserted-by":"crossref","first-page":"E1115","DOI":"10.1097\/BRS.0000000000001580","article-title":"Meta-analysis of the impact of patient characteristics on estimates of effectiveness and harms of recombinant human bone morphogenetic protein-2 in lumbar spinal fusion","volume":"41","author":"Laurie","year":"2016","journal-title":"Spine"},{"issue":"6","key":"10.1016\/j.spinee.2026.09.007_bib0025","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.spinee.2011.04.023","article-title":"A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned","volume":"11","author":"Carragee","year":"2011","journal-title":"Spine J"},{"issue":"12","key":"10.1016\/j.spinee.2026.09.007_bib0026","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1007\/s00586-015-3870-9","article-title":"Complications and cancer rates in spine fusion with recombinant human bone morphogenetic protein-2 (rhBMP-2)","volume":"25","author":"Vavken","year":"2016","journal-title":"Eur Spine J"},{"issue":"6","key":"10.1016\/j.spinee.2026.09.007_bib0027","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jclinepi.2013.10.019","article-title":"The statistical significance of randomized controlled trial results is frequently fragile: a case for a fragility index","volume":"67","author":"Walsh","year":"2014","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"10.1016\/j.spinee.2026.09.007_bib0028","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/01.BRS.0000048469.45035.B9","article-title":"Radiographic assessment of interbody fusion using recombinant human bone morphogenetic protein type 2","volume":"28","author":"Burkus","year":"2003","journal-title":"Spine"}],"container-title":["The Spine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1529943026006698?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1529943026006698?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T11:33:38Z","timestamp":1791632018000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1529943026006698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":28,"alternative-id":["S1529943026006698"],"URL":"https:\/\/doi.org\/10.1016\/j.spinee.2026.09.007","relation":{},"ISSN":["1529-9430"],"issn-type":[{"value":"1529-9430","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Costs and outcomes of recombinant human bone morphogenetic protein-2 usage in single-level posterior or transforaminal lumbar interbody fusion in a propensity score-matched national, retrospective cohort","name":"articletitle","label":"Article Title"},{"value":"The Spine Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.spinee.2026.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}